Ulcerative colitis: open trials in Lithuania

9 open trials have a site in Lithuania. Registry data; only the trial team decides who can take part.

NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas · Klaipeda University hospital, Klaipėda · Viesoji Istaiga Klaipedos Miesto Poliklinika, Klaipėda
Registry updated 2026-11-04
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Klaipedos universiteto ligonine VšĮ, Klaipeda · Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius · Inlita UAB, Vilnius
Registry updated 2026-11-03
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Klaipedos universiteto ligonine VšĮ, Klaipeda · Vilniaus universiteto ligonine Santaros klinikos VšĮ, Vilnius · Inlita UAB, Vilnius
Registry updated 2026-10-27
NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Kaunas
Registry updated 2026-10-23
2025-524404-29-00
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Trial Treatment · Phase 2 · Eli Lilly & Co.
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, Kaunas · Klaipedos universiteto ligonine VšĮ, Klaipeda · Klaipėdos Miesto poliklinika, Klaipeda
Registry updated 2026-10-21
NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Sanofi
Kaunas · Panevezys
Registry updated 2026-10-16
2024-520201-39-00
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics Inc.
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, Kaunas
Registry updated 2026-07-31
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Kaunas · Vilnius University Hospital Santaros Klinikos, Vilnius
Registry updated 2026-05-07
NCT06850727
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics, Inc.
The Hospital of Lithuanian University of Health Sciences, Kaunas
Registry updated 2026-02-11

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error